Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - Open House Biologics Discount Agreements 2024-10 - Pertuzumab / Trastuzumab (Drug Combination)
Deadline - Dec 31, 2026
GT reference number - 97554873
Product classification - Pharmaceutical products
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 97554873
Document Type - Tender Notices
Description - Description: The health insurance companies involved aim to conclude discount agreements with all suitable pharmaceutical companies in accordance with Section 130c Paragraph 1 of the Social Security Code (SGB V) for the active ingredient combination pertuzumab/trastuzumab. The contract is concluded as part of the open house biologics procedure of the health insurance companies involved: Individual negotiations on the contents of the contract are not conducted; uniform conditions apply. The health insurance companies involved do not guarantee individual contractual partners exclusivity. The contract term is a maximum of 24 months starting on January 1, 2025. The contract ends on December 31,
Gt Ref Id - 97554873
Deadline - Dec 31, 2026
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database